Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: An on-field national study

Advances in Therapy

Volumn 29, Issue 4, 2012, Pages 312-326

  Durando, Paolo ^a   Alicino, Cristiano ^a   Alberti, Marisa ^a   Sticchi, Laura ^a   Turello, Valter ^b   Marensi, Lorenzo ^b   Caiazzo, Anna Luisa ^c   Panico, Maria Grazia ^c   Accurso, G ^g   Adinolfi, M ^g   Agliata, R ^g   Albanese, E ^g   Angeli, C ^g   Arenare, L ^g   Avino, A ^g   Barberis, I ^g   Benigni, M ^g   Borzone, F ^g   Cacciani, R ^g   Caprile, S ^g   Cardamone, G ^g   Coluccio, R ^g   Compagnino, F ^g   Coppola, T ^g   D'Anna A ^g   Della Monica, A ^g   Di Cianni, E ^g   Di Marzio, L ^g   Farro, A ^g   Fiore, F ^g   Fusillo, C ^g   Gallo, D ^g   Iudici, R ^g   Mantero, P ^g   Marchetti, C ^g   Martini, M ^g   Nasto, R ^g   Opisso, A ^g   Petrucci, A ^g   Rocco, M ^g   Ronga, C ^g   Rosselli, R ^g   Rossi, S ^g   Sannino, N ^g   Sibilio, R ^g   Simoni, M C ^g   Sinopoli, T ^g   Varone, A ^g   Visconti, M ^g   Viscosi, C ^g   Vyshka, S ^g   Zacconi, M ^g   more..

^a UNIVERSITY OF GENOA   (Italy)

^b Local Public Health Unit of Genoa (ASL 3 Genovese)   (Italy)

^c Local Health Unit 1 of Salerno   (Italy)

^d Naples Local Health Unit No1   (Italy)

^e Local Health Unit Naples2   (Italy)

^f Rome H   (Italy)

^g NONE

Author keywords

Acceptance; Elderly; Immunization; Influenza; Intradermal vaccine; Revaccination; Safety; Survey

Indexed keywords

INFLUENZA VACCINE;

AGED; ARM MOVEMENT; ARTICLE; CONTROLLED STUDY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE CONTUSION; INJECTION SITE ECCHYMOSIS; INJECTION SITE ERYTHEMA; INJECTION SITE HARDENING; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE REDNESS; INJECTION SITE SWELLING; ITALY; MAJOR CLINICAL STUDY; MALE; MYALGIA; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT SATISFACTION; QUESTIONNAIRE; SKIN INDURATION; SLEEP; SYSTEMIC DISEASE; UNSPECIFIED SIDE EFFECT;

EID: 84863719193     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-012-0012-1     Document Type: Article

References (26)

1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86. (Pubitemid 36068705)
2. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84. (Pubitemid 24284768)
3. World Health Organization (WHO). Influenza vaccines. Wkly Epidemiol Rec 2005;80:279-87.
4. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1128-32.
5. Ministero de la Salute. Prevenzione e controllo dell'influenza: raccomandazioni per la stagione 2011-2012. Available at http://www. normativasanitaria.it/normsan-pdf/0000/39451-1.pdf. Accessed Jan 19, 2012. In Italian.
6. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006;24:1159-69. (Pubitemid 43202262)
7. Nichol KL. The efficacy, effectiveness and costeffectiveness of inactivated influenza virus vaccines. Vaccine 2003;21:1769-75. (Pubitemid 36398371)
8. Durando P, Icardi G, Ansaldi F. MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk. Expert Opin Biol Ther 2010;10:639-51.
9. Ansaldi F, Durando P, Icardi G. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin Biol Ther. 2011;11:415-27.
10. Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008;7:1201-14.
11. Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 2008;26:3197-208.
12. Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Available at www.emea.europa.eu/ humandocs/PDFs/EPAR/intanza/H-957-en6.pdf.Accessed Jan 19, 2012.
13. Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009;7:13.
14. Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomized controlled safety and immunogenicity trial in adults. Vaccine 2008;26:6614-9.
15. Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008;198:650-8.
16. Arnou R, Icardi G, De Decker M, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009;27:7304-12.
17. Van Damme P, Arnou R, Kafeja F, et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. BMC Infect Dis 2010;10:134.
18. Ministero de la Salute. Prevenzione e controllo dell'influenza: raccomandazioni per la stagione 2010-2011. Available at http://www.governo.it/ backoffice/allegati/59423-6206.pdf. Accessed Jan 19, 2012.
19. Chevat C, Viala-Danten M, Dias-Barbosa C, Nguyen VH. Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaire. Health Qual Life Outcomes. 2009;7:21.
20. World Health Organization (WHO). Adding a vaccine to a national immunization programme: decision and implementation. November 2005. Available at: http://whqlibdoc.who.int/hq/2005/ WHO-IVB-05.18.pdf. Accessed Jan 19, 2012.
21. Reygrobellet C, Viala-Danten M, Meunier J, Weber F, Nguyen VH. Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials. Hum Vaccin 2010;6:336-45.
22. Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of IntanzaR 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther 2011;28:640-9.
23. Prymula R, Usluer G, Altinel S, Sichova R, Weber F. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey. Adv Ther 2012;29:41-52.
24. Arnou R, Frank M, Hagel T, Prebet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011;28:555-65.
25. Ansaldi F, de Florentiis D, Durando P, Icardi G. Fluzone(R) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults. Expert Rev Vaccines 2012;11:17-25.
26. Durando P, Iudici R, Alicino C, et al. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Hum Vaccin 2011;7:211-6.